New Study Demonstrates Clinical Validity of EarlyCDT-Lung(TM) KANSAS CITY, Kansas, Aug. 5 /PRNewswire/ — Oncimmune® (USA) LLC, provider of EarlyCDT-Lung(TM), a elementary red blood exam which aids physicians in risk comment as well as a early showing of lung cancer, currently voiced a announcement of a investigate which demonstrates a clinical effect of a test. The investigate patrician “Clinical Validation of an Autoantibody Test for Lung Cancer Diagnosis” is right away accessible …
Product Description Glioblastoma multiforme (GBM) is the many usual as well as assertive first brain growth in adults as well as confers the gloomy prognosis. Despite heated effort, diagnosis stays the poignant healing plea as well as latest modalities have been desperately needed. In new years the race of cancer cells with neural branch dungeon (NSC)-like properties has been reported in GBM. It is hypothesized which these so- called brain cancer stem-like cells (bCSC) have been concerned in brain t… More >>
Commission upon Cancer Launches National Pilot Study For Expansion of Geisinger Health System’s Provencare Methodologies … A inhabitant commander investigate which will foster evidence-based analysis as well as diagnosis standards for patients with resectable non tiny dungeon lung cancer (NSCLC) was launched yesterday by a Commission upon Cancer (CoC) of a American College of Surgeons. The Commission upon Cancer National Pilot Study for a ProvenCare(r) Lung Cancer Collaborative is formed upon a success of a Geisinger Health System …
Study finds ultrasound protected for following the little ovarian tumors Certain formidable ovarian tumors might be safely monitored regulating ultrasound but raising the risk of ovarian cancer, according to the latest study.
Nektar ovarian cancer drug benefits women in study About 48 percent of women with modernized ovarian cancer saw postulated benefits from diagnosis with Nektar Therapeutics’ initial drug NKTR-102 in a mid-stage study, a association pronounced upon Sunday.
Positive primary formula from Nektar Therapeutics’ NKTR-102 Phase 2 investigate for metastatic breast cancer Nektar Therapeutics currently voiced certain rough primary formula from a two-stage Phase 2 clinical investigate evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have perceived a before taxane. The increasing operate of taxanes in breast cancer mostly renders tumors resistant to these drug by a time a mildew recurs, thereby underscoring a obligatory need …
BSD Medical Reports Impressive Results From Clinical Study On Pancreatic Cancer Presented At ESHO 2010 Meeting BSD Medical Corporation (NASDAQ: BSDM) reported considerable formula from the clinical investigate upon the operate of hyperthermia, delivered regulating the BSD-2000 Hyperthermia System, to provide pancreatic cancer. Dr. S. Maluta, University Hospital of Verona, Italy, reported the formula of the randomized Phase II investigate of 74 patients with modernized pancreatic cancer: “Hyperthermia total with radiochemotherapy in …
Karmanos Cancer Institute Researchers Study Bisphosphonates as well as Their Affect upon Early Stage Breast Cancer CHICAGO, Jun 5 /PRNewswire-USNewswire/ — Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented rough interpretation which shows nitrogen-containing bisphosphonates, healing agents used to foster bone illness as well as stop resorption, might means the somewhat poorer presence rate in post-menopausal women with early theatre breast cancer who take them for their anti-osteoporosis …
Mayo Clinic Study Identifies Surgical Means For Improving Kidney Cancer Survival Significance of the Mayo Research”Mayo Clinic maintains the Renal Nephrectomy Registry which presents thirty years of renal cancer operation result metrics,” says Dr. Leibovich. “Our research shows which the poignant suit of patients with mixed renal dungeon carcinoma metastases will knowledge improved outcomes if all metastases have been removed.”The investigate compared presence of 3 groups of cancer …
